Home » Topics » BioWorld Science

BioWorld Science
RSS

New RIP-1 inhibitors discovered at Roche, Genentech

May 9, 2018

Intravenous formulation of Akynzeo launched in the U.S.

May 9, 2018

Cellcentric divulges new KAT3 and/or CREB-binding protein inhibitors

May 9, 2018

Nektar Therapeutics initiates phase Ib trial of NKTR-358 in patients with SLE

May 9, 2018

Novartis describes novel IKACh channel blockers

May 9, 2018

Novel serine palmitoyltransferase inhibitors identified at Takeda

May 9, 2018

Durable antidepressive effect seen with ALKS-5461 in phase III trial

May 9, 2018

Dare Bioscience enters agreement with Pear Tree Pharmaceuticals to secure rights to PT-101

May 9, 2018

Valeant Pharmaceuticals International to change name to Bausch Health Companies

May 8, 2018

FDA grants fast track designation to Debio-1347

May 8, 2018

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...